Melatonin inhibits chondrosarcoma cell proliferation and metastasis by enhancing miR‐520f‐3p production and suppressing MMP7 expression
Journal of Pineal Research · 2023
DOI: 10.1111/jpi.12872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pineal Research, 2023. Verfasst von Bao Tran Nguyen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: MicroRNAs, Melatonin, Chondrosarcoma. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: China Medical University, Taiwan, Ministry of Science and Technology, Taiwan, China Medical University Beigang Hospital.
Abstract (Originalsprache)
Chondrosarcoma has a high propensity to metastasize and responds poorly to chemotherapy and radiation treatment. The enzymatic activity of matrix metalloproteinases (MMPs) is very important in chondrosarcoma metastasis. Melatonin exhibits anticarcinogenic activity in many types of cancers by suppressing the expression of certain MMP family members, but this has not yet been clearly determined in chondrosarcoma. Our study demonstrates that MMP7 plays an essential role in chondrosarcoma cell proliferation, migration, and anoikis resistance. We also found that MMP7 is highly expressed in chondrosarcomas. Our in vitro and in vivo investigations show that melatonin strongly inhibits chondrosarcoma cell proliferation, migration, and anoikis resistance by directly suppressing MMP7 expression. Melatonin reduced MMP7 synthesis by promoting levels of miR‐520f‐3p expression, which were downregulated in human chondrosarcoma tissue samples. Pharmacological inhibition of miR‐520f‐3p markedly reversed the effects of melatonin upon chondrosarcoma proliferation and metastasis. Thus, our study suggests that melatonin has therapeutic potential for reducing the tumorigenesis and metastatic potential of chondrosarcoma via the miR‐520f‐3p/MMP7 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan.
- Translational Medicine Center, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
- Department of Medicine, Mackay Medical College, New Taipei, Taiwan.
- Division of Spine Surgery, Department of Orthopedic Surgery, MacKay Memorial Hospital, New Taipei, Taiwan.
- Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan.
- Department of Orthopedic Surgery, China Medical University Beigang Hospital, Yunlin, Taiwan.
ORCID-Profile: Bao Tran Nguyen
Förderung
- China Medical University, Taiwan
- Ministry of Science and Technology, Taiwan
- China Medical University Beigang Hospital
- China Medical University Hospital
- Shin Kong Wu Ho-Su Memorial Hospital
Zitieren
APA
Nguyen, B. T., Lin, C. Y., Chang, T. K., Fong, Y. C., Thadevoos, L. A., Lai, C. Y., Huang, Y. L., Tsai, C. H., Ko, C. Y., Liu, J. F., Yang, S. F., & Tang, C. H. (2023). Melatonin inhibits chondrosarcoma cell proliferation and metastasis by enhancing miR‐520f‐3p production and suppressing MMP7 expression. Journal of Pineal Research. https://doi.org/10.1111/jpi.12872
Vancouver
Nguyen BT, Lin CY, Chang TK, Fong YC, Thadevoos LA, Lai CY, et al. Melatonin inhibits chondrosarcoma cell proliferation and metastasis by enhancing miR‐520f‐3p production and suppressing MMP7 expression. Journal of Pineal Research. 2023. doi:10.1111/jpi.12872
BibTeX
@article{Nguyen2023,
author = {Nguyen, Bao Tran and Lin, Chih-Yang and Chang, Ting-Kuo and Fong, Yi-Chin and Thadevoos, Louis Anoop and Lai, Chao-Yang and Huang, Yuan-Li and Tsai, Chun-Hao and Ko, Chih-Yuan and Liu, Ju-Fang and Yang, Shun-Fa and Tang, Chih-Hsin},
title = {Melatonin inhibits chondrosarcoma cell proliferation and metastasis by enhancing miR‐520f‐3p production and suppressing MMP7 expression},
journal = {Journal of Pineal Research},
year = {2023},
doi = {10.1111/jpi.12872}
}
EUVIMED